BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6236341)

  • 1. Construction of human suppressor T cell hybridomas.
    Greene WC; Depper JM; Leonard WJ; Fleisher TA; Waldmann TA
    Lymphokine Res; 1983; 2(2):53-60. PubMed ID: 6236341
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of human suppressor T cell hybridomas.
    Greene WC; Fleisher TA; Nelson DL; Waldmann TA
    J Immunol; 1982 Nov; 129(5):1986-92. PubMed ID: 6214585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic activity of an idiotype-bearing suppressor T cell factor produced by a long-term T cell hybridoma.
    Takaoki M; Sy MS; Whitaker B; Nepom J; Finberg R; Germain RN; Nisonoff A; Benacerraf B; Greene MI
    J Immunol; 1982 Jan; 128(1):49-53. PubMed ID: 6459378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of TCR alpha-chains into suppressor and T helper cell hybridomas. Production of suppressor factors with predicted antigen specificity.
    Kuchroo VK; Byrne MC; Greenfield E; Whitters MJ; Nalefsky EA; Rao A; Collins M; Dorf ME
    J Immunol; 1995 May; 154(10):5030-8. PubMed ID: 7730610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the IgE response by IgE class-specific suppressor T hybridomas.
    Suemura M; Sugimura K; Ishizaka A; Kobatake S; Shiho O; Deguchi H; Kishimoto S; Yamamura Y; Kishimoto T
    Curr Top Microbiol Immunol; 1982; 100():79-88. PubMed ID: 6212197
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissection of a suppressor cell cascade.
    Dorf ME; Okuda K; Minami M
    Curr Top Microbiol Immunol; 1982; 100():61-7. PubMed ID: 6178561
    [No Abstract]   [Full Text] [Related]  

  • 7. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.
    Denis KA; Wall R; Saxon A
    J Immunol; 1983 Nov; 131(5):2273-8. PubMed ID: 6313803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction.
    O'Hara RM; Byrne MC; Kuchroo VK; Nagelin A; Whitters MJ; Jayaraman S; Henderson SL; Dorf ME; Collins M
    J Immunol; 1995 Mar; 154(5):2075-81. PubMed ID: 7868884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence of conventional anti-picryl T suppressor factor in the contact sensitivity system and monoclonal anti-NP TsF3: their final non-specific effect via the T acceptor cell.
    Asherson GL; Dorf ME; Colizzi V; Zembala M; James BM
    Immunology; 1984 Nov; 53(3):491-7. PubMed ID: 6333385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihelper T cell autoantibody in acquired agammaglobulinemia.
    Rubinstein A; Sicklick M; Mehra V; Rosen FS; Levey RH
    J Clin Invest; 1981 Jan; 67(1):42-50. PubMed ID: 6450224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.
    Kobayashi Y; Asada M; Higuchi M; Osawa T
    J Immunol; 1982 Jun; 128(6):2714-8. PubMed ID: 7042845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culture conditions that optimize outgrowth of hybridomas.
    Hamilton MJ; Davis WC
    Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of a suppressor factor by human adherent cells treated with Mycobacterium tuberculosis: absence in systemic lupus erythematosus.
    Wadee AA; Gear AJ; Rabson AR
    Clin Exp Immunol; 1981 Oct; 46(1):82-8. PubMed ID: 6461455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization and pharmacologic modulation of the synthesis and/or secretion of histamine-induced suppressor factor (HSF).
    Rocklin RE
    Lymphokine Res; 1983; 2(2):61-5. PubMed ID: 6088902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human suppressor cells.
    Panayi GS
    Agents Actions Suppl; 1980; 7():121-5. PubMed ID: 6454332
    [No Abstract]   [Full Text] [Related]  

  • 16. Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma.
    Dillman SL; Aldenderfer P; Strelkauskas A
    Hum Antibodies Hybridomas; 1994; 5(1-2):32-40. PubMed ID: 7858181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of a suppressor factor by adherent cells from Mycobacterium tuberculosis-infected guinea-pigs.
    Wadee AA; Rabson AR
    Clin Exp Immunol; 1981 Aug; 45(2):427-32. PubMed ID: 6459198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppressor T- and B-lymphocytes].
    Khaitov RM
    Probl Gematol Pereliv Krovi; 1981 Oct; 26(10):48-54. PubMed ID: 6459576
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is late-appearing idiopathic hypogammaglobulinemia a suppressor T lymphocyte disease?].
    Estruch R; Vernet M; Fernández-Huerta JM; Suesa N; Urbano-Márquez A; Rozman C
    Med Clin (Barc); 1984 Jun; 83(2):58-60. PubMed ID: 6236343
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant.
    Nakano T; Ishii Y; Ishizaka K
    J Immunol; 1996 Mar; 156(5):1728-34. PubMed ID: 8596020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.